BRIEF published on 04/07/2026 at 08:05, 2 days 10 hours ago Spineway's General Meeting Approves Resolutions Growth Strategy Shareholders General Meeting Resolutions Spineway
PRESS RELEASE published on 04/07/2026 at 08:00, 2 days 10 hours ago SPINEWAY : Minutes of the General Meeting of April 2, 2026 Spineway shareholders approved resolutions at the General Meeting, except for one. CEO thanks shareholders for support. Next event: April 30, 2026 - first-quarter revenue announcement Shareholders Revenue General Meeting CEO Spineway
BRIEF published on 02/17/2026 at 19:05, 1 month 19 days ago Spineway Reports 4% Revenue Growth for 2025 Financial Results Revenue Growth 2025 Spineway Spinal Implants
PRESS RELEASE published on 02/17/2026 at 19:00, 1 month 19 days ago Spineway : 2025 annual results Spineway reports 4% revenue growth and improved financial results in 2025, strengthening growth potential. Board approves financial statements, emphasizing net income improvement Financial Results Revenue Growth Net Income Growth Potential Spineway
BRIEF published on 01/13/2026 at 18:35, 2 months 27 days ago Spineway: 2025 Review and Q4 Growth Revenue Strategic Diversification Spineway Q4 Growth Spinal Implants
BRIEF published on 10/22/2025 at 08:35, 5 months 18 days ago Evolution Surgical to distribute Spineway disc prostheses in Australia Australia Distribution Spineway Surgical Evolution Disc Prostheses
BRIEF published on 10/14/2025 at 18:52, 5 months 25 days ago Spineway Reports Positive Third Quarter Revenue Growth Revenue Growth Spineway Export Sales Third Quarter 2025 Premium Ranges
PRESS RELEASE published on 10/14/2025 at 18:47, 5 months 26 days ago Spineway : Revenue growth in the third quarter Spineway Group reports 18% revenue growth in Q3 2025 driven by Premium ranges and strong performance in Latin America and Asia Revenue Growth Latin America Q3 2025 Premium Ranges Spineway Group
BRIEF published on 07/30/2025 at 19:29, 8 months 9 days ago Spineway: Half-yearly review 2025 and outlook Financial Results Treasury Growth Spineway Spinal Implants
PRESS RELEASE published on 07/30/2025 at 19:24, 8 months 9 days ago Spineway : H1 2025 results - Continued improvement in results and financial position Spineway reports improved H1 2025 results with net loss narrowing by €2 million. Revenue target for 2025 confirmed. Solid cash position of €4 million as of June 30, 2025 Revenue Growth Financial Performance Cash Position Spineway H1 2025 Results
Published on 04/09/2026 at 16:00, 2 hours 52 minutes ago Banff Half Marathon Completes 2025 Emissions Assessment, Supporting Climate Action with Karbon-X
Published on 04/09/2026 at 14:40, 4 hours 12 minutes ago Silver X Delivers Production Growth During the First Quarter of 2026
Published on 04/09/2026 at 14:00, 4 hours 52 minutes ago Orogen Royalties Announces Mineral Reserve and Resource Update on Producing Ermitaño Royalty
Published on 04/09/2026 at 13:30, 5 hours 22 minutes ago Datametrex Receives $6M Purchase Order for Data Centre from Fortune 500 Conglomerate
Published on 04/09/2026 at 13:30, 5 hours 22 minutes ago ESGold Advances Toward Production and Exploration Drilling as Mill Buildout Progresses in Parallel
Published on 04/09/2026 at 18:15, 36 minutes ago REPLY: Launch of a share buyback program for a maximum number of 3,607,950 shares
Published on 04/09/2026 at 15:40, 3 hours 12 minutes ago Form 8.3 - The Vanguard Group, Inc.: LondonMetric Property plc
Published on 04/09/2026 at 15:39, 3 hours 12 minutes ago Form 8.3 - The Vanguard Group, Inc.: Schroders plc
Published on 04/09/2026 at 18:35, 17 minutes ago Availability of proxy documents for the Combined General Meeting of April 30, 2026
Published on 04/09/2026 at 15:57, 2 hours 54 minutes ago Filing of CNP Assurances SA 2025 universal registration document and 2025 Solvency and Financial Condition Reports
Published on 04/09/2026 at 07:00, 11 hours 52 minutes ago bioMérieux Unveils its BIOFIRE® SPOTFIRE® Molecular Testing Solution for the Pharmaceutical Industry, Redefining Rapid Mycoplasma Testing
